A 67-year-old female suffered envenoming by a Sydney funnel-web spider (Atrax robustus), complicated by ST elevation and elevated troponin levels consistent with an acute myocardial injury. She was treated primarily with funnel-web spider antivenom, admission to intensive care and initial respiratory support for acute pulmonary oedema. The mechanism by which funnel-web spider envenomation caused myocardial injury is unclear but follow-up nuclear studies in the patient demonstrated that she had minimal atherosclerotic disease.
Funnel-web spiders are arguably the most toxic spiders to humans in the world 1, 2 . They are confined to eastern Australia, including the large population centres of Sydney and Newcastle. Prior to antivenom becoming available in the 1980s, there had been 13 documented deaths attributed to FWS since the first reported death in 1927 3 . All fatalities had occurred in adult females or children 2 .
Funnel-web spiders (Hexathelidae: Atrax and Hadronyche) are large black burrowing spiders belonging to the group of primitive spiders (mygalomorphae). Their venom contains a number of toxins, the clinically important ones being the deltaatracotoxins which inhibit sodium channel inactivation 4,5 causing massive neurotransmitter release and an autonomic storm in humans. Funnel-web spider envenoming is characterized by initial local pain at the bite site followed rapidly by fasciculations (localized and generalized), paraesthesia (perioral and distal limb), massive autonomic outflow (generalized diaphoresis, hyperlacrimation, salivation and mydriasis/miosis), cardiovascular effects (tachycardia, hypertension) and non-cardiogenic pulmonary oedema. Prior to the availability of anti-venom, severe envenoming occasionally resulted in intractable hypotension, coma and death, despite modern intensive care 6 . Despite the significant envenoming syndrome that these spiders cause, information about the spectrum and severity of effects is incomplete. There are no large series of cases of funnel-web spider bite although there are case reports and a small case series 1,7-10 .
CASE REPORT
A 67-year-old female presented following a bite by a male funnel-web spider. She had been gardening and at about noon, while picking up some leaves, felt a bite on her right little finger and then saw a black spider near her hand. She squashed the spider and brought it into the hospital for identification. She had immediate severe pain at the bite site. Her son applied a tight bandage from the fingers up to the elbow and she was transported to the local hospital. She had a history of type II diabetes, hypercholesterolaemia, and polymyalgia rheumatica. She had a 40 pack year history of cigarette smoking and had previously been diagnosed with hypertension. She was taking prednisone 7.5 mg daily and metformin 2 g daily in divided doses.
On arrival at hospital 30 minutes after the bite she was unwell with drooling, pronounced generalized sweating and lacrimation, shaking, paraesthesia in the feet, hand and lips, and vomiting. On examination she had a heart rate (HR) of 114, blood pressure (BP) 146/100 mmHg, respiratory rate (RR) 24 and oxygen saturation (SpO 2 ) 93% (on 50% oxygen). There were two puncture marks on her right 5th finger. Respiratory examination was unremarkable. Her electrocardiogram (ECG) showed sinus tachycardia at a rate of 115 bpm and there was >2 mm ST elevation in leads V 3 to V 6 ( Figure 1 ). She was administered oxygen and immediately treated with intravenous atropine 0.6 mg, funnel-web spider antivenom two ampoules (500 U) and metoclopramide 10 mg.
On examination 45 minutes after the bite she remained unwell with HR 148, BP 180/98 mmHg, SpO 2 93% (on 50% oxygen) and an arterial blood gas (ABG) showed pH 7.33, PCO 2 30 mmHg, PO 2 72 mmHg and HCO 3 -17 mmol/l. Bibasal crepitations were present on chest auscultation. A further two ampoules of antivenom were administered and the decision to transfer her to the regional toxicology unit was made after consultation with a clinical toxicologist.
Her condition continued to deteriorate over the next hour requiring 70% oxygen by a non-rebreathing mask and then continuous positive airway pressure (CPAP). Repeat ABG 90 minutes after the bite showed pH 7.29, PCO 2 44 mmHg, PO 2 63 mmHg and HCO 3 -20 mmol/l on CPAP 5 cm H 2 O pressure and 100% oxygen. At this time HR was 125 bpm and BP 83/45 mmHg. She had ongoing hypersalivation, lacrimation and fasciculations.
The retrieval team arrived 110 minutes after the bite and a further two ampoules of funnel-web spider anti-venom were administered (a cumulative total of six ampoules). Although the autonomic features of envenoming improved and her BP was 146/80 mmHg and HR 119 bpm, she had worsening respiratory failure unresponsive to CPAP. Rapid sequence intubation was performed, followed by muscle relaxation with vecuronium (10 mg) and sedation with morphine and midazolam infusions prior to transfer.
On arrival in the intensive care unit at the receiving hospital 3.5 hours after the bite, HR was 110 bpm, BP 150/65, with mild hypersalivation and lacrimation. Breath sounds were normal on chest auscultation. Her chest radiograph had evidence of interstitial oedema and her ECG showed 2-3 mm of ST elevation in leads V 3 to V 6 consistent with an acute anterior injury. Her troponin T was elevated 1.3 (normal <1.0) and creatine kinase (CK) 462 IU (normal <225 IU). She was commenced on intravenous heparin, aspirin 100 mg daily and her regular medications.
Over the next 12 hours her blood pressure stabilized and her systolic BP remained between 100 and 120 mmHg, and she was no longer tachycardic. She was weaned from the ventilator and extubated 20 hours after the bite. At this time she had no evidence of increased secretions, but she had coarse crepitations on chest auscultation and an audible S 3 . Her chest radiograph confirmed interstitial oedema and she had evolving ECG changes with deep symmetrical T wave inversion in V 3 to V 6 . She was treated with intravenous frusemide 20 mg and referred to the cardiology team for ongoing care.
She was moved to the Coronary Care Unit and 26 hours after the bite underwent cardiology review. At this time she was haemodynamically stable and had no chest pain or dyspnoea. She still had bibasal coarse crepitations and an added heart sound. An echocardiogram showed normal left ventricular size with apical akinesia and mild hypokinesia of the basal, anterior and posterior walls.
She remained in the Coronary Care Unit for a further four days. Her chest radiograph was normal two days after the bite and clinical signs of cardiac failure had resolved. She was discharged home and was followed up. Her ECG two months after the bite showed minor non-specific ST segment and T wave changes in the inferolateral leads. An exercise Sestamibi nuclear scan demonstrated a mild inferior wall perfusion defect and gated images showed normal wall motion and thickening with left ventricular ejection fraction (LVEF) of 56%.
The spider was identified by Dr Mike Gray at the Australian museum as a large male Sydney funnelweb spider, Atrax robustus. 
DISCUSSION
This is the first reported case of funnel-web spider envenoming causing an acute myocardial injury. Deaths have previously been reported from Australian funnel-web spiders 2,6,11 and widow spiders from many countries 12, 13 , but no deaths have been directly attributed to venom-induced ST elevation myocardial infarction. The patient was managed by early administration of antivenom which may have prevented further myocardial damage and death.
Although the toxin-mediated mechanisms leading to pulmonary oedema in funnel-web spider bites are poorly understood, it appears to be a venom induced non-cardiac lung injury. There is no evidence to suggest that funnel-web spider venom or its components cause direct myocardial toxicity 5 . For this reason the mechanism of venom induced or associated myocardial injury is difficult to ascertain. It is most likely a result of either coronary artery spasm induced by venom or secondary release of mediators such as catecholamines; or, venom induced decrease in coronary blood flow (tachycardia and catecholamine surge) and pre-existing coronary vessel disease. It is impossible to determine which without a coronary angiogram, but this was not clinically indicated in the patient during the acute phase of the illness and follow-up nuclear scan assessment is consistent with only very mild underlying coronary disease. In particular no perfusion defect was identified in the anterior wall corresponding to the site of the most marked ST segment elevation during the acute phase which implies that the initial changes were secondary to the effects of envenoming rather than coronary atheroma and thrombosis.
This case poses important management issues for subsequent cases of funnel-web spider bite induced ST elevation, suggestive of an acute myocardial injury. Without an understanding of the mechanism of injury, the indications for early thrombolysis are unclear. It would have no benefit in patients with coronary artery spasm and the risk of cerebral haemorrhage in an envenomed patient with significant hypertension and autonomic instability would be significant. If there are progressive ECG changes consistent with an ST elevation myocardial infarction, and other signs of envenoming have resolved with or without antivenom treatment, then a non-venom induced mechanism of myocardial injury is more likely. In these cases appropriate investigation and management should proceed in a similar way to any presentation of ST elevation myocardial infarction.
The use of funnel-web spider antivenom should be the mainstay of treatment and be initiated in larger than normal starting doses, as early as possible. The initial dose is normally two ampoules 14 for funnel-web envenoming. We recommend an initial dose of four ampoules in the setting of ST elevation followed within 30 minutes with a second dose of four ampoules if evidence of significant envenoming has not resolved. After the administration of eight ampoules and persistent ECG changes, standard treatment for ST elevation myocardial infarction should be seriously considered, particularly in patients with a history of coronary artery disease. Primary coronary angiography, if immediately available, is the investigation of choice to determine the aetiology of reduced coronary blood flow and allow re-vascularization if required. The more rapid administration and use of large doses of antivenom in our patient may have prevented the development of more extensive damage and cardiac failure.
